CHD4-induced up-regulation of ERα activity contributes to breast cancer progression  

作　　者：Aman Sattout Xiaomin Yu Zhuo Sun Yanan Li Yulin Li Shujing Li Wei Huo Huijian Wu 

机构地区：[1]School of Bioengineering&Key Laboratory of Protein Modification and Disease,Liaoning Province,Dalian University of Technology,Dalian,Liaoning 116024,China [2]Department of Oncology,Central Hospital Affiliated with Dalian University of Technology,Dalian,Liaoning 116089,China

出　　处：《Genes & Diseases》2024年第3期132-135,共4页基因与疾病（英文）

基　　金：We thank Professor Wei Cheng(Dalian Medical University)for generously offering T47D,MCF7,ZR-75-1,and SK-BR-3 breast cancer cells and Professor WeiGuo Zhu(Peking University Health Science Center)for providing the full-length human Flag-CHD4,GFP-CHD4,and GST-CHD4 plasmids.

摘　　要：The estrogen signaling system is a crucial regulator of metabolicandphysiologicalprocesses.However,abnormal activation of estrogen signaling may play a role in breast cancer initiation and progression.Crucial to this pathway is the interaction between estrogen receptor alpha(ERa)and various co-transcription activators.1 Although numerous studies have investigated ER coregulators,the protein-protein interaction networks of ERa are not fully understood.Recent research has shown that high chromodomain helicase DNA-binding 4(CHD4)expression is linked to poor prognosis in various cancers.2,?In this study,we demonstrated that both CHD4 and ERαcontribute to breast cancer progression while providing evidence of the regulatory processes and functional interplay between these two proteins.

关 键 词：BREAST CANCER ERΑ 

分 类 号：R737.9[医药卫生—肿瘤]